{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:18:50Z","timestamp":1783351130132,"version":"3.54.6"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:p>This cohort study compares antibiotic prophylaxis prescription timing among children with sickle cell disease born between 2008 and 2022 to identify whether suboptimal uptake of antibiotic prophylaxis is due to the timely receipt of the first prescription by 3 months of age.<\/jats:p>","DOI":"10.1001\/jamapediatrics.2026.0653","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:30:35Z","timestamp":1776699035000},"page":"792","source":"Crossref","is-referenced-by-count":0,"title":["First Antibiotic Prophylaxis Prescription Among Children With Sickle Cell Disease"],"prefix":"10.1001","volume":"180","author":[{"given":"Jiajing Scarlette","family":"Shi","sequence":"first","affiliation":[{"name":"Georgia Health Policy Center, Andrew Young School of Policy Studies, Georgia State University, Atlanta"},{"name":"Department of Public Management and Policy, Andrew Young School of Policy Studies, Georgia State University, Atlanta"},{"name":"Jimmy and Rosalynn Carter School of Public Policy, Georgia Institute of Technology, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"LaFon","sequence":"additional","affiliation":[{"name":"Georgia Department of Public Health, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Sutaria","sequence":"additional","affiliation":[{"name":"Georgia Department of Public Health, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon Kyle","family":"Attell","sequence":"additional","affiliation":[{"name":"Georgia Health Policy Center, Andrew Young School of Policy Studies, Georgia State University, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Georgia Health Policy Center, Andrew Young School of Policy Studies, Georgia State University, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Tang","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"},{"name":"Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela B.","family":"Snyder","sequence":"additional","affiliation":[{"name":"Georgia Health Policy Center, Andrew Young School of Policy Studies, Georgia State University, Atlanta"},{"name":"Department of Public Management and Policy, Andrew Young School of Policy Studies, Georgia State University, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"pld260011r2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5863\/1551-6776-15.3.152","article-title":"Penicillin prophylaxis in children with sickle cell disease.","volume":"15","author":"Cober","year":"2010","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"25","key":"pld260011r3","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial.","volume":"314","author":"Gaston","year":"1986","journal-title":"N Engl J Med"},{"issue":"4","key":"pld260011r4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060804","article-title":"National quality indicators in pediatric sickle cell anemia.","volume":"153","author":"Anderson","year":"2024","journal-title":"Pediatrics"},{"issue":"3","key":"pld260011r5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-2182","article-title":"Antibiotic prophylaxis for children with sickle cell anemia.","volume":"141","author":"Reeves","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"pld260011r6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijns10010022","article-title":"Current methods of newborn screening follow-up for sickle cell disease are highly variable and without quality assurance: results from the ENHANCE study.","volume":"10","author":"Galadanci","year":"2024","journal-title":"Int J Neonatal Screen"},{"key":"pld260011r1","unstructured":"Appropriate antibiotic prophylaxis for children with sickle cell disease. Agency for Healthcare Research and Quality. August 2021. Accessed May 29, 2025. https:\/\/www.ahrq.gov\/pqmp\/measures\/scd-antibiotic-prophylaxis.html"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2847888\/jamapediatrics_shi_2026_ld_260011_1782854680.71916.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:00:40Z","timestamp":1783350040000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2847888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2026.0653","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}